CClinicalTrials.gg
CompletedNCT06280183Updated Mar 27, 2026

Functional Inspiratory Muscle Training in Obese Individuals

An interventional study of Functional Inspiratory Muscle Training and Aerobic+Resistive Exercise Traning in Obesity, sponsored by Biruni University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 25 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by Biruni University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
25 Years to 60 Years
Sex
All
01

Study summary

In obese individuals, increased adipose tissue and systemic inflammation play a key role in the development of cardiometabolic diseases, pulmonary system dysfunction, and many respiratory diseases. Existing research has demonstrated beneficial clinical outcomes of inspiratory muscle training or combined aerobic and resistance exercise training in obese individuals. However, this focused on the isolated effects of exercise on obesity. In the current literature, no study is evaluating the effectiveness of functional inspiratory muscle training in obese individuals.

This study aims to investigate the effects of functional inspiratory muscle training on body composition, cardiometabolic markers, functional capacity, respiratory function, respiratory muscle strength, and respiratory muscle performance in obese individuals.

Read the detailed description

Obesity is characterized by increased adipose tissue and systemic inflammation that play a key role in the development of non-communicable chronic diseases. It is well known that individuals with obesity have decreased exercise capacity and muscle weakness in both peripheral and respiratory muscles.

Exercise training is recommended in addition to healthy dietary habits in managing obesity. Current literature demonstrated beneficial clinical outcomes of isolated inspiratory muscle training or combined aerobic and resistance exercise training in obese individuals.

Functional inspiratory muscle training is a method that combines both aerobic exercise and inspiratory muscle training. In the current literature, no study is evaluating the effectiveness of functional inspiratory muscle training in obese individuals. The aim of this study is to investigate the effect of functional inspiratory muscle training on body composition, cardiometabolic markers, functional capacity, respiratory function, respiratory muscle strength and respiratory muscle performance in obese individuals.

02

Conditions studied

  • Obesity

Keywords

  • obesity
  • respiratory muscle training
  • exercise
  • prevention
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 45 is below the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Biruni University is the lead sponsor of 172 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Those between the ages of 25-60
  • According to the World Health Organization (WHO) classification, those with a body mass index between 30-40 kg/m2
  • Volunteering to participate in the research

Exclusion criteria

Exclusion Criteria:

  • According to the World Health Organization (WHO) classification, body mass index is over 40 kg/m2
  • Functional class III or IV according to the New York Heart Association (NYHA) classification
  • Those with a Charlson comorbidity score of 3 and above
  • Uncontrolled hypertension, diabetes and unstable angina pectoris
  • Cooperative disorders, orthopedic and neurological problems that may interfere with evaluation and treatment
  • Individuals with a history of lower extremity-related injury or surgery in the last six months
  • Being diagnosed with diabetes and having complications such as nephropathy, retinopathy and neuropathy
  • Those with accompanying chronic respiratory disease
  • Those with acute infection
  • Individuals with middle ear-related pathologies (such as tympanic membrane rupture, otitis)
  • Those with a STOP-Bang score of 3 and above
  • Individuals with a history of spontaneous or trauma-related pneumothorax
  • Smokers
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
45 participants (actual)

Study arms

  • Active comparator
    Aerobic and Resistive Exercise Training

    The exercise program will start with a 5-10 minute warm-up and end with a 5-10 minute cool down. Aerobic exercise is planned at 60-85% of Maximum Heart Rate on the bike for 30-40 minutes. Resistive exercise program, covering all major major muscle groups; The upper body (pectoralis, latissimus dorsi, rotator cuff muscles, deltoid, biceps, triceps), abdominal muscles and lower extremities (quadriceps, hamstring, gastrosoleus) will be exercised to strengthen. For upper body muscles, abdominal muscles and lower extremity muscles, 1-3 sets of 10-15 repetitions will be planned as 40-70% of 1 maximum repetition (1RM).

    Other: Aerobic+Resistive Exercise Traning

  • Experimental
    Functional Inspiratory Muscle Training Group in obese individuals:

    Inspiratory muscle training will be applied simultaneously with aerobic exercise. This program will create the functional IMT. The exercise program will start with a 5-10 minute warm-up and cool down. Aerobic exercise is planned at 60-85% of MHR on the bike for 30-40 minutes, progress will be achieved. Participants will first work with bicycle ergometry and then continue with IMT in the same session for the first three weeks. The intensity of IMT exercise will be set at 40-60% of MIP. After 10 consecutive breathing cycles, participants will be asked to perform 3-4 breath checks. Resistive exercise program, covering all major muscle groups; The upper body (pectoralis, latissimus dorsi, rotator cuff muscles, deltoid, biceps, triceps), abdominal muscles and lower extremities (quadriceps, hamstring, gastrosoleus) will be exercised to strengthen. For upper body muscles, abdominal muscles and lower extremity muscles, 1-3 sets of 10-15 repetitions will be planned as 40-70% of 1RM.

    Other: Functional Inspiratory Muscle Training

  • No intervention
    Control Group:

    Patient education will be given and no intervention will be made.

Interventions

  • OtherFunctional Inspiratory Muscle Training

    Inspiratory muscle training is a technique that combines aerobic training with inspiratory muscle training. will be applied simultaneously with aerobic exercise. Participants will work with bicycle ergometry and then continue with IMT in the same session for the first three weeks. The intensity of IMT exercise will be set at 40-60% of MIP.

  • OtherAerobic+Resistive Exercise Traning

    Aerobic exercise is planned at 60-85% of the Maximum Heart Rate on a cycle ergometer for 30-40 minutes. Resistive exercise will cover all major muscle groups. The upper body (pectoralis, latissimus dorsi, rotator cuff muscles, deltoid, biceps, triceps), abdominal muscles, and lower extremities (quadriceps, hamstring, gastrosoleus) will be exercised to strengthen. For upper body, abdominal, and lower extremity muscles, 1-3 sets of 10-15 repetitions will be planned as 40-70% of 1 maximum repetition (1RM).

06

What researchers measure

Primary outcomes

  1. Functional Capacity

    Submaximal functional exercise capacity of the participants will be evaluated with six- minute walk test.

    Time frame: 10 weeks

Secondary outcomes

  1. Comorbidity Assessment

    "Charlson Comorbidity Index" (CMI) will be used to determine the comorbidity levels of obese individuals. The index, which consists of nineteen comorbid diagnosis groups, is a valid method for evaluating chronic diseases and measuring their relationship with mortality. All CMI scores are scored between 0-37. According to the results, 3 levels of comorbidity are defined: low (0), medium (1-2) and high (3+).

    Time frame: Day 1

  2. Physical Activity Assessment

    Step Count Measurement: Daily step count will be monitored to determine the physical activity level of the participants. Step count will be assessed with a wearable activity monitor, a portable, easy-to-use tool that can measure objectively (Huawei Watch Fit Special Edition). With its six-axis sensor, the device records the user's physical activity style information in its temporary memory throughout the duration of use. Participants will be asked to wear the activity monitor on their left wrist throughout and only remove it during bathing. After one week of use, the data recorded with the wearable activity monitor will be taken.

    Time frame: 10 weeks

  3. Edmonton Obesity Staging System (EOSS)

    The Edmonton Obesity Staging System (EOSS) is a five-stage obesity classification system used to determine prognosis and guide treatment when assessing obesity-related risk.

    Time frame: Day 1

  4. Peripheral Muscle Strength

    M. Quadriceps muscle strength and hand grip strength measurement will be used to evaluate peripheral muscle strength. Hand-held dynamometer will be used to evaluate quadriceps muscle strength and hand grip strength.

    Time frame: 10 weeks

  5. Waist circumference

    Waist circumference will be measured at belly level with the patient in an upright position during expiration, with both feet bearing equal weight.

    Time frame: 10 weeks

  6. Hip circumference

    Hip circumference will be measured at the level of the greater femoral trochanter, with the patient in an upright position, with both feet bearing equal weight.

    Time frame: 10 weeks

  7. Body fat-muscle ratios

    These measurements will be determined by bioelectrical impedance.

    Time frame: 10 weeks

  8. Glucose profile

    Glucose profile after 12 hours of fasting will be measured

    Time frame: 10 weeks

  9. Lipid profile

    Lipid profile after 12 hours of fasting will be measured

    Time frame: 10 weeks

  10. Respiratory Muscle Strength

    Respiratory muscle strength; it will be evaluated with an intraoral pressure measuring device in a sitting position.

    Time frame: 10 weeks

  11. Incremental load test (Respiratory muscle endurance)

    Respiratory muscle endurance will be evaluated by incremental load test. The incremental load test will be performed using the electronic inspiratory loading device (PowerBreathe-KHP2)

    Time frame: 10 weeks

  12. Forced expiratory volume 1st second (Respiratory function)

    Spirometric assessment will be performed to determine participants' forced expiratory volume in one second (FECV1).

    Time frame: 10 weeks

  13. Forced vital capacity (Respiratory function)

    Spirometric assessment will be performed to determine participants' forced vital capacity (FVC)

    Time frame: 10 weeks

07

Study locations

1 site
  • Biruni University
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06280183
Lead sponsor
Biruni University
Collaborators
Istanbul Galata University
Responsible party
Buket AKINCI (Assoc.Prof., Biruni University) — Principal investigator
First posted
Feb 28, 2024
Start date
Feb 28, 2024
Primary completion
Aug 30, 2025
Completion
Mar 23, 2026
Last update
Mar 27, 2026

Study contacts

Buket Akinci, Assoc. Prof.
study chair · Biruni University
Alihan Oral, Assoc. Prof.
study director · Biruni University Hospital
Safak Yigit, MSc
principal investigator · Biruni University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion